Adjustments to the preanalytical phase of quantitative cell-free DNA analysis


Evaluating the kinetics of cell-free DNA (cfDNA) in the blood of cancer patients could be a strong auxiliary component to the molecular characterization of cfDNA, but its potential clinical significance is obscured by the absence of an analytical consensus. To utilize quantitative cfDNA assessment with confidence, it is crucial that the preanalytical phase… (More)
DOI: 10.1016/j.dib.2015.12.009


1 Figure or Table